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Health economic modeling is a branch of decision-analytic
modeling often undertaken for the purpose of economic evalua-
tion of health care technologies. It has been defined by its appli-
cation of mathematical techniques to synthesize available informa-
tion about healthcare processes and their implications, thereby
providing an explicit two-way bridge between primary data and the
decisions they inform.1
The role of health economic modeling for informing policy
decisions have evolved rapidly over the past decade. In particular,
since the National Institute for Health and Clinical Excellence
(NICE) in 2004 published their updated guideline on how to
appraise new and existing technologies, it could be read to favor
modeling over trial-based studies for the purpose of economic
evaluation.2
The benefit of screening for abdominal aortic aneurysm
(AAA) has been demonstrated in large clinical trials and several
cost-effectiveness evaluations have followed from the UK, Finland,
USA, Canada, Sweden, The Netherlands, France, and Denmark.
While there is no reason to suspect that AAA behave differently
across the borders concerning growth and rupture, structural
differences in populations and health care systems typically restrict
the results to specific settings. For example, there will be variation
concerning attendance, prevalence of AAA, incidental detection
rates, proportion of ruptures reaching surgery, proportion fit for
repair, surgical outcomes, survival, and costs.
The present Italian model establishes a model structure that is
comparable to what we have seen in previous models. The popu-
lation of the model is largely based on relevant national and
international sources, although they have been selected qualita-
tively (and not upon systematic literature search and/or meta-PH, PhD, Viborg, Denmark
Concerns have been raised about the credibility of health
conomic models due to a lack of transparency of earlier reports.3
n a forthcoming review on recent models of screening for AAA,
e observed some improvements on the previously identified poor
eporting standards.4 However, a lack of model validation (com-
aring model outputs to observed outputs of eg, a randomized
linical controlled trial or to national mortality statistics) remains a
hreat to the credibility of health economic models, including the
resent Italian model. Furthermore, it is our view that modeling
omplex regimens of eg, screening for AAA usually cannot be
ppropriately documented in a scientific manuscript of three to
000 works. A separate technical paper is therefore warranted to
ake the methodology fully transparent and to justify the under-
ying assumptions. A health economic model inherently is a sim-
lified representation of the real world.
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